- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 231/24 - SeparationPurification
Patent holdings for IPC class C07C 231/24
Total number of patents in this class: 281
10-year publication summary
|
24
|
18
|
15
|
18
|
33
|
17
|
16
|
14
|
16
|
13
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| GE Healthcare AS | 206 |
19 |
| Resonac Corporation | 3503 |
9 |
| Showa Denko K.K. | 2075 |
8 |
| BASF SE | 21313 |
7 |
| Tate & Lyle Technology Limited | 234 |
7 |
| Supercritical Fluid Technologies, Inc. | 18 |
6 |
| Les Laboratoires Servier | 496 |
5 |
| Newron Pharmaceuticals S.p.A. | 58 |
5 |
| Zhejiang Huahai Pharmaceutical Co., Ltd. | 218 |
5 |
| Mitsubishi Chemical Corporation | 4717 |
4 |
| Paratek Pharmaceuticals, Inc. | 106 |
4 |
| Novo Nordisk A/S | 2284 |
4 |
| Anhui Jinhe Industrial Co., Ltd. | 93 |
3 |
| Crystal PharmaTech Co., Ltd | 84 |
3 |
| Geron Corporation | 147 |
3 |
| Instituto Superior Tecnico | 163 |
3 |
| Shanghai Institute of Pharmaceutical Industry | 127 |
3 |
| Teva Pharmaceutical Industries Ltd. | 654 |
3 |
| Teva Pharmaceuticals USA, Inc. | 646 |
3 |
| UPL Limited | 629 |
3 |
| Other owners | 174 |